Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SHBG | P04278 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19463967 | 1.00 | SHBG (0.34) | SHBGCYP1A2SMN1; SMN2 | |
| SCHEMBL3720695 | 0.98 | SHBG (0.31) | SHBGCYP1A2 | |
| SCHEMBL15657859 | 0.93 | — | — | |
| SCHEMBL28257302 | 0.92 | SHBG (0.30) | SHBG | |
| SCHEMBL2174474 | 0.87 | CYP1A2 (0.40) | SHBGCYP1A2 | |
| SCHEMBL15655957 | 0.87 | CYP1A2 (0.40) | SHBGCYP1A2 | |
| SCHEMBL15654725 | 0.85 | CYP1A2 (0.39) | CYP1A2 | |
| SCHEMBL115420 | 0.81 | SHBG (0.42) | SHBGCYP1A2 | |
| SCHEMBL15657687 | 0.80 | DNM1 (0.36) | CYP1A2 | |
| SCHEMBL15657156 | 0.80 | DNM1 (0.41) | CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 230 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024038044-A1 | PROCESS FOR THE PREPARATION OF BIO-BASED OLEFINS FROM PRIMARY ALCOHOL | BASF SE (DE) | 2024-02-22 | — | — | WO | claimed |
| EP-4281436-A1 | SYNTHESIS OF POLYFLUORINATED ARYL AND HETEROARYL CARBOXAMIDES | BASF SE (DE) | 2023-11-29 | — | — | EP | claimed |
| EP-4132902-A1 | PD-CATALYZED AMINATION OF FLUORINATED ARYL CHLORIDES | BASF SE (DE) | 2023-02-15 | — | — | EP | claimed |
| CN-115298160-A | Pd-catalyzed amination of fluorinated aryl chlorides | 巴斯夫欧洲公司 | 2022-11-04 | — | — | CN | claimed |
| EP-3130024-B1 | POLYMER ELECTROLYTE COMPOSITION AND POLYMER ELECTROLYTE MEMBRANE, POLYMER ELECTROLYTE MEMBRANE WITH CATALYST LAYER, MEMBRANE ELECTRODE ASSEMBLY, AND POLYMER ELECTROLYTE FUEL CELL EACH USING THE SAME | TORAY INDUSTRIES (JP) | 2020-02-19 | — | — | EP | claimed |
| CN-106133975-B | Polymer electrolyte composition and the polymer dielectric film and polymer electrolyte fuel cells for using it | 东丽株式会社 | 2019-10-01 | — | — | CN | claimed |
| US-10186725-B2 | Polymer electrolyte composition and polymer electrolyte membrane, polymer electrolyte membrane with catalyst layer, membrane electrode assembly, and polymer electrolyte fuel cell each using the same | TORAY INDUSTRIES, INC. (JP) | 2019-01-22 | — | — | US | claimed |
| EP-3130024-A1 | POLYMER ELECTROLYTE COMPOSITION AND POLYMER ELECTROLYTE MEMBRANE, POLYMER ELECTROLYTE MEMBRANE WITH CATALYST LAYER, MEMBRANE ELECTRODE ASSEMBLY, AND POLYMER ELECTROLYTE FUEL CELL EACH USING THE SAME | Toray Industries, Inc. (JP) | 2017-02-15 | — | — | EP | claimed |
| US-20170033387-A1 | POLYMER ELECTROLYTE COMPOSITION AND POLYMER ELECTROLYTE MEMBRANE, POLYMER ELECTROLYTE MEMBRANE WITH CATALYST LAYER, MEMBRANE ELECTRODE ASSEMBLY, AND POLYMER ELECTROLYTE FUEL CELL EACH USING THE SAME | CELLCENTRIC GMBH & CO. KG (DE) | 2017-02-02 | — | — | US | claimed |
| WO-2015155979-A1 | POLYMER ELECTROLYTE COMPOSITION AND POLYMER ELECTROLYTE MEMBRANE, POLYMER ELECTROLYTE MEMBRANE WITH CATALYST LAYER, MEMBRANE ELECTRODE ASSEMBLY, AND POLYMER ELECTROLYTE FUEL CELL EACH USING THE SAME | TORAY INDUSTRIES, INC. (JP) | 2015-10-15 | — | — | WO | claimed |
| WO-2012158660-A1 | PHOTOINITIATOR AND PHOTOCURABLE COMPOSITIONS AND USES | EASTMAN KODAK COMPANY (US) | 2012-11-22 | — | — | WO | claimed |
| EP-1598053-B1 | Use of a composition containing at least one phosphine as majority reducing agent to remove the artificial colour of keratinic fibres | OREAL (FR) | 2006-12-20 | — | — | EP | claimed |
| EP-1598053-A1 | Use of a composition containing at least one phosphine as majority reducing agent to remove the artificial colour of keratinic fibres | L'OREAL (FR) | 2005-11-23 | — | — | EP | claimed |
| US-20050251928-A1 | Method for stripping artificial color from keratin fibers | L'OREAL (FR) | 2005-11-17 | — | — | US | claimed |
| US-6437175-B2 | MILD REACTION CONDITIONS | AVENTIS RESEARCH & TECHNOLOGIES GMBH & CO KG (DE) | 2002-08-20 | — | — | US | claimed |
| EP-1202952-A1 | METHOD FOR PRODUCING AMINES BY HOMOGENEOUSLY CATALYZED REDUCTIVE AMINATION OF CARBONYL COMPOUNDS | Degussa AG (DE) | 2002-05-08 | — | — | EP | claimed |
| US-20010031890-A1 | Process for the racemization of nu-acylamino acids by means of transition metal catalysts | AVENTIS RESEARCH & TECHNOLOGIES GMBH & CO KG (DE) | 2001-10-18 | — | — | US | claimed |
| EP-1136466-A2 | Process for racemising N-acyl-amino acids with transition metal catalysts | Aventis Research & Technologies GmbH & Co KG (DE) | 2001-09-26 | — | — | EP | claimed |
| WO-2001005741-A1 | METHOD FOR PRODUCING AMINES BY HOMOGENEOUSLY CATALYZED REDUCTIVE AMINATION OF CARBONYL COMPOUNDS | DEGUSSA AG (DE) | 2001-01-25 | — | — | WO | claimed |
| EP-0560455-B1 | Catalytic system and process for copolymerizing carbon monoxide with one or more olefins | ENICHEM SPA (IT) | 1997-05-14 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050251928-A1 | Method for stripping artificial color from keratin fibers | KRT18, DSG1, JUP | SHBG 1143/4885CYP1A2 4675/4885SMN1; SMN2 3433/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.